Abstract
Two angiotensin converting enzyme (ACE) inhibitors, trandolapril and enalapril, were compared for their effects on rat food-pad oedema induced by carrageenin, bradykinin dextran and platelet activating factor (PAF). Trandolapril (0.03–30.0 mg/kg, per os) potentiated carrageenin-induced oedemas. Enalapril produced the same effect at 3–10 fold higher doses (0.3–30.0 mg/kg per os). Both ACE inhibitors were equiactive in potentiating bradykinin-induced oedema. Neither compound affected dextran-induced oedema. In marked contrast PAF-induced oedema was reduced by both ACE inhibitors, trandolapril being approximately 10 fold more active than enalapril. The observed differences in potency between the two ACE inhibitors corresponded with their previously described actions on inhibition of plasma and tissue ACE and in inducing hypotension. The results suggest a crucial role of kinins in the oedemagenic response to carrageenin. The reason why the ACE inhibitors reduced PAF-induced oedema is not clear, but could involve peripheral vasodilation.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
C. A. Winter, E. A. Risley and G. W. Nuss,Carrageenin-induced oedema in hind paw of the rat as an assay for anti-inflammatory drugs, Proc. Soc. exp. Biol. Med.111, 544–547 (1962).
M. Di Rosa, J. P. Giroud and A. Willoughby,Studies of the mediators of the acute inflammatory response induced in rats in different sites by carrageenin and turpentine, J. Pathol.104, 15–29 (1971).
M. P. Holsapple and G. K. W. Yim,Therapeutic reduction of ongoing carrageenin induced inflammation by lipoxygenase, but not cyclooxygenase inhibitors, Inflammation8, 223–230 (1984).
G. P. Lewis,Kinins in inflammation and tissue injury. In:“Bradykinin, Kallidin and Kallikrein”. Handb. Exp. Pharmac, pp. 516–530 (Ed. E. G. Erdos). Springer-Verlag Berlin, Heidelberg (1970).
F. Marceau, A. Lussier, D. Reboli and J. P. Giroud,Pharmacology of kinins: their relevance to tissue injury and inflammation, Gen. Pharmac.14, 209–229 (1983).
J. Damas and G. Remacle-Volon,Role des kinines dans l'oedème tégumentaire déclenché par les carragénines chez le rat, J. Pharmacol. (Paris)13, 225–239 (1981).
H. Y. Yang, E. G. Erdos and Y. Levin,Characterization of a dipeptide hydrolase (kininase II: angiotensin converting enzyme), J. Pharmacol. Exp. Ther.177, 291–300 (1971).
A. L. A. Boura and A. P. Svolmanis,Converting enzyme inhibition in the rat by captopril is accompanied by potentiation of carrageenin-induced inflammation, Br. J. Pharmac.82, 3–8 (1984).
G. Caspritz, H. G. Alpermann and R. Schleyerbach,Influence of the new angiotensin converting enzyme inhibitor ramipril on several models of acute inflammation and the adjuvant arthritis in the rat, Arzneim.-Forsch./Drug Res.36, 1605–1608 (1986).
Y. Matsuno, H. Hori, M. Oka, H. Nakamura, T. Ito and T. Kadokowa,General pharmacology of the novel angiotensin converting enzyme inhibitor alacepril: effects on control nervous and sensory systems and on the other functions, Arzneim. Forsch./Drug Res.36, 62–68 (1986).
S. B. Hwang, M. H. Lam, C. L. Li and T. Y. Sen,Release of platelet activating factor and its involvement in the first phase of carrageenin-induced rat foot edema, European J. Pharmacol.120, 33–41 (1986).
N. L. Brown, J. Fichelle, J. C. Vincent and M. Worcel,Cardiovascular profile of trandolapril a new angiotensin convertin enzyme (ACE) inhibitor, Br. J. Pharmac.90, 203P (1987).
N. L. Brown, C. Chevillard and M. Worcel,Difference between trandolapril and enalapril for inhibition of tissue ACE activity in rats, Br. J. Pharmac.90, 204P (1987).
D. A. Rowley and E. P. Benditt,5-Hydroxytryptamine and histamine as mediators of the vascular injury produced by agents which damage mast cells in rats, J. exp. Med.103, 399–411 (1956).
S. Nishida, K. Kagawa and S. Tomizawa, Dextran-induced paw edema and 5-hydroxytryptamine release, Biochem. Pharmacol.28, 3149–3150 (1979).
K. F. Swingle and M. J. Reiter,Inhibition of PAF-acether-induced edema of the rat's paw, Agents and Actions18, 359–365 (1986).
J. Tamargo, T. Tejerina, C. Delgado and S. Barrigon,Electrophysiological effects of platelt-activating factor (PAF-acether) in guinea-pig papillary muscles, European J. Pharmacol.109, 219–227 (1985).
C. V. Wedmore and T. J. Williams,Platelet-activing factor (PAF), a secretory product of polymorphonuclear leucocytes, increases vascular permeability of rabbit skin, Br. J. Pharmacol.74, 916P-917P (1981).
D. M. Humphrey, L. M. McManus, K. Satouchi, D. J. Hanahan and R. N. Pinckard,Vasoactive properties of acetyl glyceryl ether phosphorylcholine and analogues, Lab. Invest.46, 422–427 (1982).
J. Bjork, L. Lindbom, B. Gerdin, G. Smedegard, K. E. Arfors and J. Benveniste,Paf-acether (platelet activating factor) increases microvascular permeability and affects endothelium-granulocyte interaction in microvascular beds, Acta Physiol. Scand119, 305–308 (1983).
J. Bjork and B. Smedegard,Acute microvascular effects of PAF-acether, as studied by intravital microscopy, European J. Pharmacol.96, 87–94 (1983).
C. S. Sweet, D. M. Gross, P. T. Arbegast, S. L. Gaul, P. M. Britt, C. L. Ludden, D. Weitz and C. A. Stone,Antihypertensive activity of N-[(S)-1-(ethoxycarbonyl)-3-phenylpropyl]-l-Ala-l-Pro (MK 421), an orally active converting enzyme inhibitor, J. Pharmacol. Exp. Ther.216, 558–566 (1981).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Jouquey, S., Brown, N.L., Fichelle, J. et al. Comparison of the effects of the ace inhibitors trandolapril and enalapril on phlogogen induced foot pad oedema in the rat. Agents and Actions 24, 297–302 (1988). https://doi.org/10.1007/BF02028286
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02028286